22 min listen
Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD
Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD
ratings:
Length:
30 minutes
Released:
May 19, 2022
Format:
Podcast episode
Description
In this episode of Back Bay’s industry podcast, The Life Science Report, Dr. Peter Bak is joined by Mike Bogetofte Barnkob, a doctor with the Department of Clinical Immunology at Odense University Hospital in Denmark and a research fellow at the University of Southern Denmark, to discuss current perspectives—clinical, scientific and manufacturing—on the cell therapy space. Dr. Barnkob’s expertise spans basic and clinical immunology, with a particular interest in advanced cellular modalities, such as chimeric antigen or CAR T-cells. He studied at the Massachusetts Institute of Technology, in Back Bay’s hometown, and completed his PhD at Oxford University. Topics in this podcast include:
The current clinical and academic uses of CAR T-cells and where they are headed in the near-term
How cellular therapies factor into a robust and thriving public healthcare-based system
Ongoing questions of pricing and reimbursement
Challenges and approval processes in getting these "living medicines" to people
Hurdles and considerations when building a Good Manufacturing Practice (GMP) cellular facility
Do you have a question about development in the cell therapy space? Drop Back Bay a line.Make sure to subscribe to our podcast and follow Back Bay Life Science Advisors on LinkedIn.Thank you for joining us.
The current clinical and academic uses of CAR T-cells and where they are headed in the near-term
How cellular therapies factor into a robust and thriving public healthcare-based system
Ongoing questions of pricing and reimbursement
Challenges and approval processes in getting these "living medicines" to people
Hurdles and considerations when building a Good Manufacturing Practice (GMP) cellular facility
Do you have a question about development in the cell therapy space? Drop Back Bay a line.Make sure to subscribe to our podcast and follow Back Bay Life Science Advisors on LinkedIn.Thank you for joining us.
Released:
May 19, 2022
Format:
Podcast episode
Titles in the series (30)
Gene Therapies: What’s to Come as The Industry Moves Forward: In this episode our host, Dr. Peter Bak, sits down with Brendan Wang and Kyle O’Neil of Back Bay Life Science Advisors to discuss the field of gene therapies and insights from their recently authored piece in Cell & Gene, “The Next Decade In Gene Therapy by Back Bay Life Science Report